HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Velcade displays promising activity in primary effusion lymphoma cells.

AuthorsDavid McConkey, Steffan T Nawrocki, Robert Andtbacka
JournalCancer biology & therapy (Cancer Biol Ther) Vol. 4 Issue 4 Pg. 491-2 (Apr 2005) ISSN: 1538-4047 [Print] United States
PMID15908793 (Publication Type: Comment, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib
Topics
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Apoptosis (drug effects)
  • Boronic Acids (pharmacology, therapeutic use)
  • Bortezomib
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Humans
  • Lymphoma, B-Cell (drug therapy, genetics, metabolism, pathology)
  • Pleural Effusion, Malignant (pathology)
  • Pyrazines (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: